Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection.
about
Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report.Risk of Hepatitis B Reactivation in Inflammatory Arthritis Patients Receiving Disease Modifying Anti-Rheumatic Drugs (DMARDs): a Systematic Review and Meta-analysis.Safety profile of biological therapies for treating rheumatoid arthritis.The practice pattern of hepatitis b testing in rheumatoid arthritis patients: A cross-national comparison between US and Taiwan.Prevention of HBV reactivation in patients treated with biologic agents.
P2860
Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety of Abatacept in Rheumat ...... t Hepatitis B Virus Infection.
@en
type
label
Safety of Abatacept in Rheumat ...... t Hepatitis B Virus Infection.
@en
prefLabel
Safety of Abatacept in Rheumat ...... t Hepatitis B Virus Infection.
@en
P2093
P2860
P356
P1476
Safety of Abatacept in Rheumat ...... t Hepatitis B Virus Infection.
@en
P2093
Alessandro Mathieu
Anastasio Grilli
Eleonora Bruschi
Eleonora Celletti
Elisabetta Lanciano
Fabiola Atzeni
Francesca Zuliani
Francesco Trotta
Leopoldo Giani
Marcello Govoni
P2860
P304
P356
10.1002/ACR.22786
P577
2015-11-10T00:00:00Z